First line combination therapy improves progression-free survival in…
Credit: ©ESMO LUGANO-GENEVA, Dec. 7, 2017 – A new combination therapy for the first line treatment of advanced non-squamous non-small-cell lung cancer (NSCLC) improves progression-free...












